A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer
Status:
Completed
Trial end date:
2016-11-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess two treatment strategies (leuprorelin treatment and
active surveillance without androgen deprivation) for indolent prostate cancer and to compare
their therapeutic benefit for management of patients with low-risk, localized prostate
cancer.